Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INVITAE CORPORATION

(NVTA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/16/2021 06/17/2021 06/18/2021 06/21/2021 06/22/2021 Date
30.13(c) 32.3(c) 32.79(c) 33.34(c) 33.12(c) Last
3 045 159 4 375 087 6 646 345 3 079 945 2 373 591 Volume
-1.25% +7.20% +1.52% +1.68% -0.66% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 464 M - -
Net income 2021 -568 M - -
Net Debt 2021 353 M - -
P/E ratio 2021 -12,2x
Yield 2021 -
Sales 2022 655 M - -
Net income 2022 -575 M - -
Net Debt 2022 323 M - -
P/E ratio 2022 -12,4x
Yield 2022 -
Capitalization 6 619 M 6 619 M -
EV / Sales 2021 15,0x
EV / Sales 2022 10,6x
Nbr of Employees 2 300
Free-Float 96,6%
More Financials
Company
Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016, the Company's products consisted of assays totaling over 1,100 genes that could be used for... 
More about the company
Ratings of Invitae Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about INVITAE CORPORATION
06/21INVITAE  : Wells Fargo Adjusts Invitae's Price Target to to $35 From $30, Keeps ..
MT
06/17INVITAE  : Insiders Make Significant Stock Sales in Invitae (NVTA) Shares Extend..
MT
06/17INSIDER TRENDS : 90-Days of Insider Buying at Invitae Eased Back with Share Disp..
MT
06/16INSIDER TRENDS : Insider Disposition Eases Back 90-Day Buy Trend at Invitae
MT
06/16INSIDER TRENDS : Invitae Insider Sale Scales Back 90-Days of Buys
MT
06/16INSIDER TRENDS : Invitae Insider Disposition Interrupting 90-Day Buy Trend
MT
06/16INSIDER TRENDS : 90-Day Insider Buying Trend Reduced with Disposition of Invitae..
MT
06/15INVITAE  : Raymond James Initiates Coverage on Invitae With Outperform Rating, $..
MT
06/11INVITAE  : appoints technology and medtech veteran Roxi Wen as chief financial o..
PU
06/11INVITAE CORP  : Change in Directors or Principal Officers, Submission of Matters..
AQ
06/11INVITAE  : Taps Former Mozilla Executive as CFO
MT
06/11INVITAE  : appoints technology and medtech veteran Roxi Wen as chief financial o..
PR
06/03INVITAE  : opens early access to liquid biopsy-based Personalized Cancer Monitor..
PR
06/03INVITAE  : Goldman Sachs Starts Invitae at Neutral With $33 Price Target
MT
05/25INVITAE  : Wells Fargo Starts Invitae at Equal-Weight With $30 Price Target
MT
More news
News in other languages on INVITAE CORPORATION
04/06MÄRKTE ASIEN/Uneinheitlich - Australische Tourismusaktien gesucht
04/05FEIERTAGS-ÜBERBLICK Unternehmen/5. April 2021
04/05MÄRKTE ASIEN/Starker US-Arbeitsmarkt schiebt Börsen an
03/02Pharming start genetisch testprogramma in VS en Canada
02/10SoftBank invertirá US$900 millones en Pacific Biosciences
More news
Analyst Recommendations on INVITAE CORPORATION
More recommendations
Chart INVITAE CORPORATION
Duration : Period :
Invitae Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INVITAE CORPORATION
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 33,12 $
Average target price 42,67 $
Spread / Average Target 28,8%
EPS Revisions
Managers and Directors
NameTitle
Sean Emerson George Chairman, President & Chief Executive Officer
Shelly D. Guyer Chief Financial Officer
Robert Nussbaum Chief Medical Officer
Eric Olivares Chief Science Officer
Layton Wedgeworth Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
INVITAE CORPORATION-20.78%6 619
EXACT SCIENCES CORPORATION-3.65%21 900
GUARDANT HEALTH, INC.-6.90%12 134
BGI GENOMICS CO., LTD.-7.47%7 570
ADAPTIVE BIOTECHNOLOGIES CORPORATION-32.56%5 596
CAREDX, INC26.72%4 779